1. Home
  2. PRTA vs GRVY Comparison

PRTA vs GRVY Comparison

Compare PRTA & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$8.76

Market Cap

429.2M

Sector

Health Care

ML Signal

N/A

Logo GRAVITY Co. Ltd. American Depository Shares

GRVY

GRAVITY Co. Ltd. American Depository Shares

N/A

Current Price

$66.48

Market Cap

473.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
PRTA
GRVY
Founded
2012
2000
Country
Ireland
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
429.2M
473.7M
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
PRTA
GRVY
Price
$8.76
$66.48
Analyst Decision
Buy
Analyst Count
7
0
Target Price
★ $21.40
N/A
AVG Volume (30 Days)
★ 508.2K
16.4K
Earning Date
11-09-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.26
N/A
Revenue
★ $814,000.00
N/A
Revenue This Year
$754.03
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.27
★ $8.05
Revenue Growth
N/A
★ N/A
52 Week Low
$7.73
$54.54
52 Week High
$11.80
$76.00

Technical Indicators

Market Signals
Indicator
PRTA
GRVY
Relative Strength Index (RSI) 54.41 43.60
Support Level $8.08 $65.90
Resistance Level $9.18 $66.57
Average True Range (ATR) 0.38 1.15
MACD 0.03 0.05
Stochastic Oscillator 58.18 49.41

Price Performance

Historical Comparison
PRTA
GRVY

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

About GRVY GRAVITY Co. Ltd. American Depository Shares

GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. The gaming products of the company include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation. Geographically, it derives maximum revenue from Taiwan.

Share on Social Networks: